Alternatives to Neoflow Technologies

A privacy-preserving, cross-chain decentralized exchange and shielded network built for the Cosmos ecosystem.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Medical device company developing advanced sensor technology for oncology treatment.

Developing advanced bio-integrated devices for enhanced medical diagnostics and therapeutics.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Developing novel diagnostics to predict patient response to immunotherapy.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Bioz is an AI search engine for life science experimentation, helping scientists find validated and cost-effective products.

Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

Transforming healthcare by turning scientific fiction into scientific facts.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Microbiome technology platform for developing novel therapeutics.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health disorders.

Developing gene editing therapies to lower cholesterol.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Biomedical platform with intelligent search for medical citations and clinical trial recruitment.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

AI-powered breast cancer detection and risk assessment solutions.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Developing oral small molecule medicines for immunological and chronic diseases.